Add BrightSurf on Google Email

Stowers Institute's Hawley Lab identifies factors responsible for restart of meiotic cycle

The Hawley Lab has identified two molecular mechanisms that restart the meiotic cycle in oocytes, including the controlled expression of Polo kinase and the inactivation of inhibitory protein Matrimony. This discovery has significant implications for understanding egg maturation and releasing, as well as treating infertility and cancer.

SourceStowers Institute for Medical Research·JournalPLOS Biology·DateDec 4, 2007

Matrimony inhibits Polo kinase

Researchers have identified two proteins controlling the pause in meiotic division, with Matrimony preventing Polo kinase from working until sufficient levels are reached. This work may lead to new treatments for infertility and cancer, as Polo kinase is strongly expressed in tumor cells.

SourcePLOS·JournalPLOS Biology·DateDec 3, 2007

Modulating fat levels essential for successful pregnancy

A study published in JCI Journals reveals that disturbances in sphingolipid metabolism may be a key factor in early pregnancy loss. Sphingosine kinase 1 (Sphk1) and Sphk2 proteins play a crucial role in metabolizing these fats, which are essential for placental development.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 20, 2007

All eukaryotic kinases share 1 common set of substrates

A study published in PLOS ONE found that all eukaryotic kinases share a common set of substrates, suggesting that despite their diversity, these enzymes have similar functions. This discovery may improve the testing of drugs targeting protein kinases for various diseases.

SourcePLOS·JournalPLOS ONE·DateAug 21, 2007

Signal protein shows promise for blocking tumor promoters in skin cells

A study published in the Journal of Biological Chemistry found that signal protein Srcasm can block tumor-promoting molecules in skin cells, potentially leading to targeted gene therapy for certain cancers. By increasing Srcasm levels, researchers may be able to reverse uncontrolled cell growth caused by activated Src kinases.

SourceUniversity of Pennsylvania School of Medicine·JournalJournal of Biological Chemistry·DateNov 3, 2006

New insight into cell division

Researchers at Max Planck Institute for Molecular Genetics in Berlin have explained the molecular principles of cell division control mechanisms. The study found that checkpoint kinases interact with a different category of proteins involved in developing the cell division spindle.

SourceMax-Planck-Gesellschaft·JournalScience·DateOct 27, 2006

Enzyme inhibitor may provide strategy to treat some GI disorders, Jefferson researchers find

Researchers at Thomas Jefferson University found that blocking Rho kinase activity could be a viable treatment for gastrointestinal disorders such as constipation, anal fissures, and hemorrhoids. The study showed that Rho kinase inhibitors can cause direct smooth muscle relaxation and may provide a new strategy to treat these conditions.

SourceThomas Jefferson University·JournalGASTROENTEROLOGY·DateJul 18, 2006

Scientists elucidate the kinome of key model organism

Researchers at Boston Biomedical utilize bioinformatics to study the kinome of Dictyostelium, a model organism revealing unique enzymes involved in cell biology. The study identifies 46 conserved kinases across all organisms, providing insights into fundamental cellular processes.

SourcePLOS·JournalPLOS Genetics·DateMar 30, 2006

Structure of key cancer drug target identified

The research discovered the structure of JAK2 kinase, a well-validated drug target for cancer and other disorders. The discovery will enable the development of specific molecules to treat diseases where JAK kinases play a pivotal role, leading to a rapid growth of phase I therapeutics.

SourceResearch Australia·JournalBlood·DateOct 25, 2005

Building a human kinase gene repository

A new human kinase gene repository has been established, featuring a comprehensive collection of protein and non-protein kinases. The repository will facilitate high-throughput assays and structural studies of this crucial gene family, which plays key roles in various cellular processes.

SourceHarvard Medical School·JournalProceedings of the National Academy of Sciences·DateMay 23, 2005

Structure of new DNA enzyme family member found

Researchers at Cornell University have discovered a new DNA enzyme, AIRs kinase, with a shape similar to other members of the riboside kinase family. This finding suggests that proteins may evolve using similar rules, and could lead to the design of laboratory tools for testing anticancer drugs.

SourceCornell University·JournalStructure·DateNov 3, 2004

Leading the way in novel anti-cancer research

AstraZeneca scientists have discovered selective and potent inhibitors of Aurora kinase activity that may have potential application in human cancer treatment. New pre-clinical research presents a combination of vascular targeting agents with EGFR tyrosine kinase inhibitors, showing greater anti-tumor activity than either agent alone.

Novel protein is both ion channel and enzyme

Researchers have discovered a new protein component that controls calcium entry into cells and activates itself and other proteins, making it a potential new drug target for diseases like cancer and heart conditions. The protein, TRP-PLIK, is present in many tissues and its unique dual function has sparked interest among scientists.

Researchers design new way to squelch errant enzymes

Scientists have developed a novel approach to inhibit protein kinase enzymes, which play a crucial role in triggering cancers, hardening of the arteries, and autoimmune diseases. The researchers' bisubstrate analogs effectively prevent these enzymes from working, offering a promising therapeutic strategy for various diseases.

SourceJohns Hopkins Medicine·JournalNature Structural & Molecular Biology·DateJan 11, 2001

Pharmacologists Discover Linkage Of Key Cell Switches

Researchers found that an enzyme called kinase IV is regulated by another enzyme called phosphatase 2A, which attaches to it and quickly shuts it down. This discovery provides insight into how cells control their activities and offers potential for developing targeted drugs to kill cancer cells or bacteria.

SourceDuke University·JournalScience·DateJul 1, 1998